Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16336546
[patent_doc_number] => 10787490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 15/745371
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 51
[patent_no_of_words] => 73793
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745371 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Jul 14, 2016 | Issued |
Array
(
[id] => 12085952
[patent_doc_number] => 09839666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'Peptide and a use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/210323
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 7836
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15210323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/210323 | Peptide and a use thereof | Jul 13, 2016 | Issued |
Array
(
[id] => 15880445
[patent_doc_number] => 10646547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Polypeptide having chemokine activity and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/745217
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 9793
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745217
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745217 | Polypeptide having chemokine activity and uses thereof | Jul 12, 2016 | Issued |
Array
(
[id] => 12445485
[patent_doc_number] => 09981008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Apolipoprotein A-I mimics
[patent_app_type] => utility
[patent_app_number] => 15/207158
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 37
[patent_no_of_words] => 46962
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15207158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/207158 | Apolipoprotein A-I mimics | Jul 10, 2016 | Issued |
Array
(
[id] => 15147753
[patent_doc_number] => 20190352354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Human sDR5-Fc Recombinant Fusion Protein and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 16/344365
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344365 | Human sDR5-fc recombinant fusion protein and application thereof | Jul 10, 2016 | Issued |
Array
(
[id] => 11602442
[patent_doc_number] => 20170119741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/181284
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 111
[patent_no_of_words] => 17705
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/181284 | Macrocyclic lactone compounds and methods for their use | Jun 12, 2016 | Issued |
Array
(
[id] => 11457110
[patent_doc_number] => 20170051015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'METHODS OF DEVELOPING SELECTIVE PEPTIDE ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/179900
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 39660
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15179900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/179900 | Methods of developing selective peptide antagonists | Jun 9, 2016 | Issued |
Array
(
[id] => 11401717
[patent_doc_number] => 20170022256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'ANTI-FUNGAL AND ANTI-BACTERIAL PEPTIDE AND THERAPEUTIC METHOD USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/175011
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5525
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15175011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/175011 | ANTI-FUNGAL AND ANTI-BACTERIAL PEPTIDE AND THERAPEUTIC METHOD USING SAME | Jun 5, 2016 | Abandoned |
Array
(
[id] => 11596849
[patent_doc_number] => 09644001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Cell-penetrating peptides'
[patent_app_type] => utility
[patent_app_number] => 15/165754
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6450
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165754
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/165754 | Cell-penetrating peptides | May 25, 2016 | Issued |
Array
(
[id] => 11250352
[patent_doc_number] => 09475843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Antimicrobial peptide WY-21 and application thereof'
[patent_app_type] => utility
[patent_app_number] => 15/164028
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 3528
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15164028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/164028 | Antimicrobial peptide WY-21 and application thereof | May 24, 2016 | Issued |
Array
(
[id] => 12837376
[patent_doc_number] => 20180170965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PEPTIDE HAVING ANTIMICROBIAL ACTIVITY AGAINST PATHOGENS AND ANTIMICROBIAL PEPTIDE COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/512193
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512193 | Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same | May 24, 2016 | Issued |
Array
(
[id] => 12728746
[patent_doc_number] => 20180134749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => NOVEL PEPTIDE AND COMPOSITION CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/576111
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576111 | Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatment | May 24, 2016 | Issued |
Array
(
[id] => 16310788
[patent_doc_number] => 20200289526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => CONJUGATE OF FINASTERIDE WITH PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/086256
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086256 | Conjugate of finasteride with peptide | May 19, 2016 | Issued |
Array
(
[id] => 11127956
[patent_doc_number] => 20160324931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'Use of Natriuretic Peptide for Treating Heart Failure'
[patent_app_type] => utility
[patent_app_number] => 15/152220
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16292
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/152220 | Use of Natriuretic Peptide for Treating Heart Failure | May 10, 2016 | Abandoned |
Array
(
[id] => 11487086
[patent_doc_number] => 09593149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Amylin and calcitonin receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 15/151093
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 61637
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/151093 | Amylin and calcitonin receptor agonist | May 9, 2016 | Issued |
Array
(
[id] => 15306487
[patent_doc_number] => 10517925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Composition comprising KA11 polypeptide or gene encoding the same for inhibiting angiogenesis, and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/571723
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 82
[patent_no_of_words] => 9917
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571723 | Composition comprising KA11 polypeptide or gene encoding the same for inhibiting angiogenesis, and use thereof | May 3, 2016 | Issued |
Array
(
[id] => 12702283
[patent_doc_number] => 20180125927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => Human Catestatin Induces Gut Microbiota Dysbiosis
[patent_app_type] => utility
[patent_app_number] => 15/569045
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569045 | Human catestatin induces gut microbiota dysbiosis | Apr 24, 2016 | Issued |
Array
(
[id] => 12253104
[patent_doc_number] => 09925235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Tilapia piscidins for use in enhancement of wound healing'
[patent_app_type] => utility
[patent_app_number] => 15/137281
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 11351
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137281 | Tilapia piscidins for use in enhancement of wound healing | Apr 24, 2016 | Issued |
Array
(
[id] => 12880792
[patent_doc_number] => 20180185439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => METHODS AND COMPOSITIONS RELATED TO KRAS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/567655
[patent_app_country] => US
[patent_app_date] => 2016-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567655
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/567655 | Methods and compositions related to KRAS inhibitors | Apr 19, 2016 | Issued |
Array
(
[id] => 11054438
[patent_doc_number] => 20160251399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 15/093335
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26649
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15093335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/093335 | PEPTIDOMIMETIC MACROCYCLES | Apr 6, 2016 | Abandoned |